Ginkgo Biloba Certified Extract 120 mg
Goals
$39.75 $0.10 per serving
Product analysis
Ginkgo Biloba Certified Extract 120 mg is a focused option aimed at memory and attention. Mixed findings and uncertainty about the exact extract keep everyday benefits difficult to predict.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The extract’s marker compounds are named, but its form quality remains uncertain. Those declarations alone do not confirm equivalence to a particular studied extract.
Ingredient Transparency80
The amount and extract markers are stated. Their relative proportions are not disclosed, limiting detailed composition comparisons.
Value For Money40
There is not enough information to judge value for the ginkgo content. The declared amount alone does not show whether the cost is worthwhile.
Customer Satisfaction88
Customer ratings are very positive across many reviews. The broad satisfaction pattern does not establish routine improvements in focus or vision.
Product Focus58
Ginkgo provides a narrow ingredient focus across several cognitive aims. The findings are mixed, so daily focus, productivity and memory benefits remain uncertain.
- Format
Capsule - Container
- 365 Capsule(s)
- Per serving
- $0.10
- Customer rating
- 4.7 · 4,599 ratings
Goals
Impact
Moderate effect
Impact
Moderate effect
Impact
Moderate effect
Impact
Moderate effect
Impact
Moderate effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ginkgo biloba (leaf) extract (<1 ppm Ginkgolic Acid, Ginkgo Flavone Glycosides, Total Terpene Lactones) | 120 mg |
Ginkgo (<1 ppm Ginkgolic Acid, Ginkgo Flavone Glycosides, Total Terpene Lactones) · 120 mg OverallScore100
The serving lists 120 mg of Ginkgo Leaf Extract. Ginkgo Leaf Extract lists 24% flavone glycosides and 6% terpene lactones. The stated ginkgolic acid limit is below 1 ppm. Ginkgo-specific value is unavailable.
How this ingredient is rated
Composition and Label Disclosure100
Ginkgo Leaf Extract lists 24% flavone glycosides and 6% terpene lactones. The stated ginkgolic acid limit is below 1 ppm.
Marker and Preparation Disclosure
Ginkgo Leaf Extract lists 24% flavone glycosides and 6% terpene lactones.
Declared Ginkgolic Acid Limit
The stated ginkgolic acid limit is below 1 ppm.
Composition and Label Disclosure100
The serving lists 120 mg of Ginkgo Leaf Extract.
Individual Preparation Amount Disclosure
The serving lists 120 mg of Ginkgo Leaf Extract.
Commercial Price and Usability
Ginkgo-specific value is unavailable.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.
- [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].